DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neomycin and Polymyxin b Sulfates (Neomycin Sulfate / Polymyxin b Sulfate Irrigation) - Description and Clinical Pharmacology

 
 



Neomycin and Polymyxin B Sulfates
Solution for Irrigation, USP
Rx Only

NOT FOR INJECTION

DESCRIPTION

Neomycin and Polymyxin B Sulfates Solution for Irrigation is a concentrated sterile antibiotic solution to be diluted for urinary bladder irrigation. Each mL contains neomycin sulfate equivalent to 40 mg neomycin base, 200,000 units polymyxin B sulfate, and Water for Injection, inactive ingredient: sulfuric acid. The 20-mL multiple dose vial contains, in addition to the above, 1 mg methylparaben (0.1%) added as a preservative.

Neomycin sulfate, an antibiotic of the aminoglycoside group, is the sulfate salt of neomycin B and C produced by Streptomyces fradiae It has a potency equivalent to not less than 600 mcg of neomycin per mg. The structural formulae are:

Polymyxin B sulfate, a polypeptide antibiotic, is the sulfate salt of polymyxin B1 and B2 produced by the growth of Bacillus polymyxa. It has a potency of not less than 6,000 polymyxin B units per mg. The structural formulae are:

CLINICAL PHARMACOLOGY

After prophylactic irrigation of the intact urinary bladder, neomycin and polymyxin B are absorbed in clinically insignificant quantities. A neomycin serum level of 0.1 mcg/mL was observed in three of 33 patients receiving the rinse solution. This level is well below that which has been associated with neomycin-induced toxicity.

When used topically, polymyxin B sulfate and neomycin are rarely irritating.

Microbiology: The prepared Neomycin and Polymyxin B Sulfates Solution for Irrigation is bactericidal.

The aminoglycosides act by inhibiting normal protein synthesis in susceptible microorganisms. Polymyxins increase the permeability of bacterial cell wall membranes. The solution is active in vitro against:

      Escherichia coli
      Staphylococcus aureus
      Haemophilus influenzae
      Klebsiella and Enterobacter species
      Neisseria species, and
      Pseudomonas aeruginosa.

It is not active in vitro against Serratia marcescens and streptococci.

Bacterial resistance may develop following the use of the antibiotics in the catheter-rinse solution.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012